Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: A Phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study

Joseph Biederman, Suma Krishnan, Yuxin Zhang, James J. McGough, Robert L. Findling

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: A Phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study'. Together they form a unique fingerprint.

Medicine & Life Sciences